Optical Genome Mapping Helps to Identify BCR::JAK2 Rearrangement Arising from Cryptic Complex Chromosomal...

Area of Science:

• Hematology
• Genetics
• Oncology

Background:

• Myeloproliferative neoplasms (MPN) can transform into acute myeloid leukemia (AML), a complex process.
• The BCR::JAK2 rearrangement is a rare genetic abnormality associated with hematologic malignancies.
• Understanding novel genetic alterations is crucial for diagnosing and treating MPN-transformed AML.

Approach:

• Case report detailing a patient with MPN-NOS transformed AML.
• Utilized chromosomal analysis, fluorescence in situ hybridization (FISH), and optical genome mapping (OGM).
• Reviewed existing literature on BCR::JAK2 rearrangements.

Key Points:

• Identified a unique BCR::JAK2 rearrangement in AML transformed from MPN-NOS.
• OGM revealed complex chromosomal aberrations, including inv(9)(p24p13) and t(9;22)(p13;q11.2).
• Discovered novel gene disruptions (KIF24::BCR, JAK2::KIF24/UBAP1, CDK6:SOX9) possibly linked to disease progression.

Conclusions:

• The BCR::JAK2 rearrangement in AML warrants comprehensive genomic investigation.
• Novel gene disruptions identified may influence therapeutic strategies and patient outcomes.
• Further research using advanced sequencing techniques is recommended to elucidate the role of these rearrangements.